Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma – MedPage Today
|
Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma
MedPage Today CHICAGO — Immunotherapy may offer new options as second-line treatment for patients with malignant pleural mesothelioma (MPM), researchers reported here. In patients with histologically proven relapsing MPM, the median overall survival (OS) with … |
